GLP-1 receptor agonists: A novel pharmacotherapy for binge eating (Binge eating disorder and bulimia nervosa)? A systematic review-Reference-Cited by-同舟云学术

GLP-1 receptor agonists: A novel pharmacotherapy for binge eating (Binge eating disorder and bulimia nervosa)? A systematic review

Published:2024-03 Issue: Volume:35 Page:100333
ISSN:2214-6237
Container-title:Journal of Clinical & Translational Endocrinology
language:en
Short-container-title:Journal of Clinical & Translational Endocrinology

Author:

Aoun Laurence^ORCID,Almardini Shaza,Saliba Fares,Haddadin Fadi,Mourad Omar,Jdaidani Jennifer,Morcos Zeina,Al Saidi Ibrahim,Bou Sanayeh Elie,Saliba Saliba,Almardini Michel,Zaidan Julie

Publisher

Elsevier BV

Reference41 articles.

1. Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder;Claudino;J Clin Psychiatry,2007

2. Topiramate in the long-term treatment of binge-eating disorder associated with obesity;McElroy;J Clin Psychiatry,2004

3. LISDEXAMFETAMINE dimesylate effects on binge eating behaviour and obsessive–compulsive and impulsive features in adults with BED;McElroy;Eur Eat Disord Rev,2016

4. BED: a review;Dingemans;Int J Obes,2002

5. The prevalence and correlates of BED in the world health organization world mental health surveys;Kessler;Biol Psychiatry,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacovigilance study of GLP-1 receptor agonists for metabolic and nutritional adverse events;Frontiers in Pharmacology;2024-07-08

2. Discussions About Binge Eating and Type 2 Diabetes in a Facebook Group: A Qualitative Analysis;International Journal of Eating Disorders;2024-06-27